Composite
51%
Novelty
Feasibility
Impact
Mechanistic
75%
Druggability
50%
Safety
45%
Confidence
26%

Mechanistic description

This hypothesis proposes that TFEB activation can restore synaptic function in aging by simultaneously upregulating both lysosomal biogenesis and retromer complex components, creating a coordinated enhancement of the endosomal-lysosomal trafficking network. While TFEB is well-established as a master regulator of lysosomal genes, emerging evidence suggests it also controls expression of retromer components including VPS35, VPS26, and VPS29. In aged synapses, both lysosomal capacity and retromer-mediated protein sorting are compromised, leading to accumulation of misfolded proteins, defective autophagy, and synaptic dysfunction. By pharmacologically or genetically activating TFEB, we can trigger transcriptional upregulation of the entire endosomal-lysosomal machinery as a unified system. This approach leverages TFEB’s broad transcriptional control to coordinate multiple trafficking processes rather than targeting individual components in isolation. The hypothesis predicts that TFEB activation will restore proper trafficking of critical synaptic proteins like AMPA receptors, BACE1, and APP by enhancing both the retromer sorting machinery and the downstream lysosomal degradation capacity. This coordinated enhancement should be more effective than targeting either system alone, as it addresses the interconnected nature of endosomal sorting and lysosomal processing. Testing would involve measuring retromer component expression, lysosomal biogenesis markers, and protein trafficking dynamics in aged neurons following TFEB activation, with functional readouts including synaptic protein localization, autophagy flux, and electrophysiological measures of synaptic strength.

Evidence for (6)

  • TFEB overexpression reduces tau aggregation and Aβ toxicity in cellular models

  • Impaired TFEB nuclear localization observed in AD brain tissue with mTOR hyperactivation

  • Trehalose enhances lysosomal biogenesis and reduces protein aggregates in neurodegeneration models

  • Autophagosome accumulation in AD synapses indicates upstream autophagy initiation is intact but downstream lysosomal degradation is blocked

  • mTOR inhibitors (rapamycin analogs) enable TFEB nuclear translocation

  • TFEB activation bypasses upstream mTOR dysregulation and directly enhances lysosomal gene expression

Evidence against (6)

  • TFEB regulates hundreds of genes beyond lysosomal biogenesis including lipid metabolism and inflammatory pathways

  • TFEB overexpression paradoxically increases neurodegeneration in α-synuclein models via APP-like substrate processing

  • Global TFEB activation in microglia exacerbates neuroinflammation through enhanced lysosomal antigen presentation

  • TFEB haploinsufficiency is protective in certain aging paradigms, suggesting a 'Goldilocks' principle

  • Trehalose acts as chemical chaperone independently of TFEB

  • Genistein is a broad kinase inhibitor with estrogenic activity

Bayesian persona consensus

47% posterior support

1 signal · 0 for / 1 against · agreement 0%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.